Shunten International (HKG:0932) expects an attributable loss of between HK$24 million and HK$29 million for the year ended March 31, compared with a loss of HK$36 million a year prior, according to a Monday Hong Kong bourse filing.
The health supplements distributor attributed the forecast to a lower gross profit and a decline in the fair value loss on investment properties.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.